Skip to content

Study · Not a test of the peptide alone · 2026

1 result

Heterochiral co-assembly of β-strands and hairpins affords stereocomplexed peptide hydrogels for drug delivery.

Anderson CF, Wang X, Schneider JP

Journal of controlled release : official journal of the Controlled Release Society16 Apr 2026

PMID41999898 (opens in a new tab)DOI10.1016/j.jconrel.2026.114932 (opens in a new tab)PepBankPUB-41999898
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Melanotan I (afamelanotide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Melanotan I (afamelanotide).

  1. 01LabNot a test of Melanotan I (afamelanotide) aloneIn vitro (cell-free)Pharmacokinetics

    A stereocomplexed peptide hydrogel carrying afamelanotide gave slow sustained release of the active peptide over several months.

    In plain wordsIn lab tests, a peptide gel released afamelanotide slowly over several months.

    Peptide
    Melanotan I (afamelanotide)
    Outcome
    Not applicableRelease of afamelanotide from the hydrogel
    Study

    n: not reported in source

    stereocomplexed peptide hydrogel
    Outcome group
    Pharmacokinetics · Pharmacology

    Source sentences

    Summary
    The stereocomplexed delivery system offers slow sustained release of active peptide drug over several months.
    1 context sentence
    Summary · context
    Utility of this material was demonstrated through the delivery of afamelanotide, a peptide melanocortin 1 receptor agonist.

    In this study, Melanotan I (afamelanotide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Melanotan I (afamelanotide).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.